Novo Nordisk: Post-Q2 adjustments and model shift

NEUTRAL, Fair Value DKK1050 vs. DKK980 (+9%)

News published on August Friday 9, 2013
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities